Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



The role of Shock Index and its derivatives in predicting mortality in patients with upper gastrointestinal bleeding

Mehmet Seyfettin Saribas, Ali Aygun, Furkan Kara, Adem Koksal, Ibrahim Caltekin.




Abstract

Upper gastrointestinal bleeding (UGIB), a life-threatening emergency, causes significant morbidity, mortality, and healthcare costs. The mortality rate for UGIB is approximately 10%, but this rate rises to 15% in hemodynamically unstable patients. Identifying factors related to mortality and morbidity can help early detection of critical patient groups, guiding initial treatment approaches and patient management for clinicians. This study aims to investigate the performance of the Shock Index (SI) and its derivatives in predicting mortality. In the study, patients diagnosed with UGIB who presented to the Emergency Department (ED) between 2022 and 2024 were analyzed retrospectively. Patients aged 18 and over who were confirmed to have UGIB following internal medicine and/or gastroenterology consultation and were subsequently admitted to the hospital were included in the study. Of the 201 patients included in the study, 112 (55.7%) were male, with a mean age of 70.68±16.617. In-hospital mortality occurred in 17 patients (8.5%), and 30-day mortality was observed in 22 patients (10.9%). When examining the area under the curve (AUC), Age-SI (ASI) showed the best performance in predicting in-hospital mortality (AUC 0.837), followed by Age-Modified Shock Index (AMSI, AUC 0.829), MSI (AUC 0.810), and SI (AUC 0.806). ASI and AMSI can be calculated easily, cost-effectively, quickly, and practically at the time of ED presentation in UGIB patients, aiding in the early identification of critical patient groups and guiding clinicians.

Key words: Emergency medicine, mortality, risk assessment, Shock Index, upper gastrointestinal bleeding






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.